Dr. Kathryn Colby, Dr. Andrea Blitzer, and our incoming resident Jordan Mandell were at this weekend’s @FuchsSymposium in Miami! Dr. Colby presented data from the phase 2 clinical trial of ripasudil after DSO, sponsored by Kowa, Inc. #fuchsdystrophy
Amazing post-match panel tonight with some of the many fourth-year @umiamimedicine students who matched into ophthalmology residency this year! A huge thank you to them for sharing their guidance, wisdom, and pearls of advice for first - third years interested in ophthalmology!
Such a surreal feeling to match at my #1 choice, @NYULangoneEye for residency training! Sending the biggest thank you to my support system and my incredible mentors! #OphthoMatch2023#Ophthalmology
In a recent @JAMAOphth study, @RaviParikhMD and colleagues at @NYULangoneEye compare the cost-effectiveness of intravitreal anti-VEGF injections versus ranibizumab PDSA for treating neovascular age-related macular degeneration.
Read their analysis: https://t.co/q73KIGcXhs
In this analysis, #ranibizumab PDS with 1 refill was costlier than intravitreal ranibizumab and aflibercept injections if less than 11 and 10 injections, respectively, were given within the first year. https://t.co/mQxTxg42NO
1/3
A new surgical implant for #maculardegeneration is available but what are the potential safety, costs, and practical issues when #eye#injections are safe, effective, and allow for timely monitoring?
We explore this in our latest @JAMAOphth study!
https://t.co/9OfDEVHbsn
#WorldSightDay aims to bring attention to the importance of proper vision care. In collaboration with @BascomPalmerEye physicians, the Miller School Department of Community Service provided glaucoma screenings at the Little Haiti Health Fair.